Pfizer Inc (PFE)
Days of inventory on hand (DOH)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 2.02 | 2.10 | 2.50 | 2.46 | 2.80 | 2.89 | 2.42 | 3.23 | 3.87 | 3.66 | 3.71 | 3.68 | 3.42 | 2.80 | 1.87 | 1.41 | 1.26 | 1.05 | 1.15 | 1.21 | |
DOH | days | 180.81 | 173.99 | 146.01 | 148.27 | 130.59 | 126.10 | 150.56 | 112.98 | 94.30 | 99.64 | 98.45 | 99.13 | 106.77 | 130.57 | 195.48 | 259.63 | 290.57 | 346.33 | 316.74 | 302.48 |
December 31, 2024 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 2.02
= 180.81
The days of inventory on hand (DOH) for Pfizer Inc have shown fluctuations over the years based on the data provided. In recent quarters, there has been a decrease in DOH, indicating that the company is managing its inventory more efficiently.
The trend suggests that Pfizer has been able to turn its inventory into sales at a faster rate, which could be attributed to improved inventory management practices or better demand forecasting. A lower DOH indicates that the company is carrying less inventory relative to its sales, which can lead to cost savings and improved cash flow.
However, it is important for Pfizer to strike a balance with inventory levels to ensure that it can meet customer demand without facing stockouts. Monitoring DOH over time can help the company optimize its inventory levels and maintain competitiveness in the market.
Overall, the downward trend in DOH for Pfizer Inc indicates improvements in inventory management efficiency, but the company should continue monitoring and adjusting its inventory levels to align with business needs.
Peer comparison
Dec 31, 2024
See also:
Pfizer Inc Average Inventory Processing Period (Quarterly Data)